IL5 MODULATION AND THROMBOTIC RISK IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A PROOF-OF-CONCEPT MONOCENTRIC STUDY

被引：0
|
作者：
Ramirez, G. A. [1 ,2 ]
Cariddi, A. [1 ]
Lanzillotta, M. [1 ,2 ]
Benanti, G. [1 ,2 ]
Batani, V. [1 ]
Moroni, L. [1 ,2 ]
Matucci-Cerinic, M. [1 ,2 ]
Dagna, L. [1 ,2 ]
机构：
[1] IRCCS Osped San Raffaele, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
D O I：
10.1136/annrheumdis-2024-eular.5906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1101
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Monocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis
    Wang, Chrong-Reen
    Tsai, Hung-Wen
    Shieh, Chi-Chang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (07) : 802 - 810
  • [2] Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis
    Bizymi, N.
    Matthaiou, A. M.
    Stathakis, G.
    Viziriannaki, S.
    Bibaki, E.
    Tzanakis, N.
    Antoniou, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS
    Emmi, Giacomo
    Bettiol, Alessandra
    Urban, Maria Letizia
    Sinico, Renato
    Schiavon, Franco
    Caporali, Roberto
    Prisco, Domenico
    Vaglio, Augusto
    RHEUMATOLOGY, 2019, 58 : 59 - 59
  • [4] Anti-IL5 /Rituximab Therapy for Patients suffering from therapy-refractory Eosinophilic Granulomatosis with Polyangiitis
    Gysan, Maximilian Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 601 - 601
  • [5] New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors
    Holubar, Jan
    Arnaud, Erik
    Broner, Jonathan
    Pers, Yves-Marie
    Proust, Alain
    Goulabchand, Radjiv
    IMMUNOLOGIC RESEARCH, 2022, 70 (06) : 721 - 724
  • [6] New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors
    Jan Holubar
    Erik Arnaud
    Jonathan Broner
    Yves-Marie Pers
    Alain Proust
    Radjiv Goulabchand
    Immunologic Research, 2022, 70 : 721 - 724
  • [7] Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study
    Akdime, F.
    Habib, S.
    Regard, L.
    Terrier, B.
    Cohen, P.
    Mouthon, L.
    Guillevin, L.
    Burgel, P. R.
    Honore, I.
    Puechal, X.
    Roche, N.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (9-10) : 732 - 742
  • [8] Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients
    Schroeder, Jan Walter
    Folci, Marco
    Losappio, Laura Michelina
    Chevallard, Michel
    Sinico, Renato Alberto
    Mirone, Corrado
    De Luca, Fabrizio
    Nichelatti, Michele
    Pastorello, Elide Anna
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (01) : 64 - 71
  • [9] Severe Trauma Patients Requiring Undelayable Combined Cranial and Extra-Cranial Surgery: A Proof-of-Concept Monocentric Study
    Beucler, Nathan
    Sellier, Aurore
    Joubert, Christophe
    Bernard, Cedric
    Desse, Nicolas
    Esnault, Pierre
    Dagain, Arnaud
    MILITARY MEDICINE, 2022, 187 (9-10) : E1127 - E1135
  • [10] Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
    Nolasco, Santi
    Portacci, Andrea
    Campisi, Raffaele
    Buonamico, Enrico
    Pelaia, Corrado
    Benfante, Alida
    Triggiani, Massimo
    Spadaro, Giuseppe
    Caiaffa, Maria Filomena
    Scioscia, Giulia
    Detoraki, Aikaterini
    Valenti, Giuseppe
    Papia, Francesco
    Tomasello, Alessandra
    Crimi, Nunzio
    Scichilone, Nicola
    Pelaia, Girolamo
    Carpagnano, Giovanna Elisiana
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345